Results of a phase II trial of single-agent amrubicin (AMR) in patients with extensive disease small cell lung cancer (ED-SCLC) refractory to first-line platinum-based chemotherapy: An update

D. S. Ettinger; R. Jotte; P. Lorigan; V. Gupta; L. Garbo; P. Conkling; D. Spigel; R. McNally; M. Renschler; J. Oliver

Results of a phase II trial of single-agent amrubicin (AMR) in patients with extensive disease small cell lung cancer (ED-SCLC) refractory to first-line platinum-based chemotherapy: An update

D. S. Ettinger, R. Jotte, P. Lorigan, V. Gupta, L. Garbo, P. Conkling, D. Spigel, R. McNally, M. Renschler, J. Oliver

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	Undefined
Article number	8103
Journal	Journal of Clinical Oncology
Volume	27
Issue number	15 Supplement
Publication status	Published - 20 May 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Ettinger, D. S., Jotte, R., Lorigan, P., Gupta, V., Garbo, L., Conkling, P., Spigel, D., McNally, R., Renschler, M., & Oliver, J. (2009). Results of a phase II trial of single-agent amrubicin (AMR) in patients with extensive disease small cell lung cancer (ED-SCLC) refractory to first-line platinum-based chemotherapy: An update. Journal of Clinical Oncology, 27(15 Supplement), Article 8103.

@article{a1d093165f264a2cbb1683bf0dd5d07f,

title = "Results of a phase II trial of single-agent amrubicin (AMR) in patients with extensive disease small cell lung cancer (ED-SCLC) refractory to first-line platinum-based chemotherapy: An update",

author = "Ettinger, {D. S.} and R. Jotte and P. Lorigan and V. Gupta and L. Garbo and P. Conkling and D. Spigel and R. McNally and M. Renschler and J. Oliver",

year = "2009",

month = may,

day = "20",

language = "Undefined",

volume = "27",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "15 Supplement",

}

Ettinger, DS, Jotte, R, Lorigan, P, Gupta, V, Garbo, L, Conkling, P, Spigel, D, McNally, R, Renschler, M & Oliver, J 2009, 'Results of a phase II trial of single-agent amrubicin (AMR) in patients with extensive disease small cell lung cancer (ED-SCLC) refractory to first-line platinum-based chemotherapy: An update', Journal of Clinical Oncology, vol. 27, no. 15 Supplement, 8103.

Results of a phase II trial of single-agent amrubicin (AMR) in patients with extensive disease small cell lung cancer (ED-SCLC) refractory to first-line platinum-based chemotherapy: An update. / Ettinger, D. S.; Jotte, R.; Lorigan, P. et al.
In: Journal of Clinical Oncology, Vol. 27, No. 15 Supplement, 8103, 20.05.2009.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Results of a phase II trial of single-agent amrubicin (AMR) in patients with extensive disease small cell lung cancer (ED-SCLC) refractory to first-line platinum-based chemotherapy

T2 - An update

AU - Ettinger, D. S.

AU - Jotte, R.

AU - Lorigan, P.

AU - Gupta, V.

AU - Garbo, L.

AU - Conkling, P.

AU - Spigel, D.

AU - McNally, R.

AU - Renschler, M.

AU - Oliver, J.

PY - 2009/5/20

Y1 - 2009/5/20

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000276606605305&KeyUID=WOS:000276606605305

M3 - Meeting Abstract

SN - 0732-183X

VL - 27

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15 Supplement

M1 - 8103

ER -

Results of a phase II trial of single-agent amrubicin (AMR) in patients with extensive disease small cell lung cancer (ED-SCLC) refractory to first-line platinum-based chemotherapy: An update

UN SDGs

Other files and links

Cite this